JAMM Therapeutics Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
JAMM Therapeutics General Information
Description
Operator of a drug discovery company intended to develop small molecule modulators for the treatment of systemic lupus erythematosus. The company develops a deubiquitinating enzyme complex, which is a regulator of type I interferon signaling, enabling medical researchers to provide a novel and efficient treatment for SLE patients.
Contact Information
Website
www.jammtx.comCorporate Office
- Ilan Ramon Street 2
- Ness Ziona
- Israel
Corporate Office
- Ilan Ramon Street 2
- Ness Ziona
- Israel
JAMM Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 12-Oct-2022 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | 01-May-2020 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Oct-2019 | Completed | Generating Revenue |
JAMM Therapeutics Signals
JAMM Therapeutics FAQs
-
When was JAMM Therapeutics founded?
JAMM Therapeutics was founded in 2019.
-
Where is JAMM Therapeutics headquartered?
JAMM Therapeutics is headquartered in Ness Ziona, Israel.
-
What is the size of JAMM Therapeutics?
JAMM Therapeutics has 3 total employees.
-
What industry is JAMM Therapeutics in?
JAMM Therapeutics’s primary industry is Drug Discovery.
-
Is JAMM Therapeutics a private or public company?
JAMM Therapeutics is a Private company.
-
What is JAMM Therapeutics’s current revenue?
The current revenue for JAMM Therapeutics is .
-
How much funding has JAMM Therapeutics raised over time?
JAMM Therapeutics has raised $3M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process